Abeona Therapeutics Inc.
ABEO
$5.75
-$0.15-2.54%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -70.15% | 6,767.01% | |||
| Gross Profit | 70.15% | -6,767.01% | |||
| SG&A Expenses | 27.46% | 19.89% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 18.32% | 8.65% | |||
| Operating Income | -18.32% | -8.65% | |||
| Income Before Tax | -29.44% | 69.30% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -29.44% | 69.30% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -29.44% | 69.30% | |||
| EBIT | -18.32% | -8.65% | |||
| EBITDA | -18.97% | -8.58% | |||
| EPS Basic | -26.56% | 69.67% | |||
| Normalized Basic EPS | -26.57% | 69.68% | |||
| EPS Diluted | -26.56% | 69.67% | |||
| Normalized Diluted EPS | -26.57% | 69.68% | |||
| Average Basic Shares Outstanding | 2.26% | 1.24% | |||
| Average Diluted Shares Outstanding | 2.26% | 1.24% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||